Fluctuations of CD4+ T-cell subsets in remitting-relapsing multiple sclerosis

Area of Science:

• Immunology
• Neuroimmunology
• Clinical Medicine

Background:

• Multiple sclerosis (MS) is an autoimmune disease characterized by immune-mediated damage to the central nervous system.
• Patients with MS often exhibit alterations in T-cell populations, particularly CD4+ T cells, during active disease phases.
• Understanding T-cell subset dynamics is crucial for monitoring MS progression and treatment efficacy.

Observation:

• A longitudinal study monitored CD4+ and CD8+ T-cell subsets in patients with relapsing-remitting MS and healthy controls over one year.
• Peripheral blood lymphocytes were analyzed monthly using two-color immunofluorescence and fluorescence-activated cell sorting.
• Specific attention was given to CD4+ T-cell subsets, namely CD45R-CD4+ and CD45R+CD4+ T cells.

Findings:

• Significant changes in the ratio of CD45R-CD4+ to CD45R+CD4+ T cells were observed in 7 out of 9 MS patients, but not in controls.
• These ratio alterations, primarily driven by decreased CD45R+CD4+ T cells and increased CD45R-CD4+ T cells, preceded or coincided with clinical relapses (major or minor).
• One patient experienced a major relapse with a general depletion of all CD4+ T cells, independent of the specific subset ratio changes.

Implications:

• Abnormal fluctuations in specific CD4+ T-cell subsets may serve as a potential biomarker for increased disease activity in multiple sclerosis.
• These findings highlight the importance of monitoring T-cell subset dynamics for a deeper understanding of MS pathogenesis.
• Further research into these T-cell subset alterations could lead to improved diagnostic tools and targeted therapies for MS.